Hunt Anthony

The insider at CIK 0001606030 — a Repligen Corp (RGEN) executive whose Form 4 filings capture 268 transactions across a primarily RGEN-focused register — is executing a textbook option-exercise-and-partial-sell pattern at a RGEN stock price that has risen from roughly$33 in late 2023 to$157 in late 2025 — a nearly 5x appreciation that has made every in-the-money option exercise a taxable event requiring either cash outlay or partial liquidation. The two most recent filings tell the story clearly: on November 13, 2025 the insider exercised options to acquire 2,952 shares at the $33.87 grant strike and simultaneously sold 1,956 shares at$157.11, retaining roughly 1,000 shares as a net-add after the sell-to-cover cycle; on June 10–11, 2026 two larger exercises occurred — 13,656 and 14,083 shares — followed by a 2,000-share tax-lot transfer (code J) and a partial sell of 2,000 shares at the then-current market price. The pattern is deliberate and tax-efficient: exercise options in large lots (to spread transaction costs), sell just enough shares to cover the option cost and taxes, retain the remainder as a long-term hold. The register contains zero open-market discretionary sells and zero open-market discretionary buys — every transaction is initiated by the option grant schedule, not by a market view. RGEN's price appreciation from $33 to $157 through 2023–2026 has made this structure increasingly valuable to the insider, but the structure itself was not chosen because of the price appreciation — it is the standard financial-engineering response to in-the-money options. The honest read: the insider holds an unquantified but material long-term RGEN position built through years of option vesting, has consistently retained shares after each exercise cycle, and is not distributing.